CSIRO to research medical cannabis The CSIRO has secured a license to develop new medicinal cannabis products in Australia. It’s been branded a significant development for those with a variety of conditions including multiple sclerosis and chronic pain. Australia’s national science agency will play a “pivotal role” in removing the stigma of cannabis, according to […]
Read More
Medical Cannabis Doctors Australia proudly supports the Greens recently tabled Bill in NSW Parliament to legalise cannabis for general adult use. While the bill is primarily aimed at ‘recreational’ cannabis consumption, the component to allow people to grow a small number of plants in their own home would greatly increase access for cannabis patients in […]
Read More
We are delighted to announce new free listing options for medical cannabis clinics and GPs across Australia. Consistent with our nearly 5 year mission to improve patient access via education and transparency, our platform is now not only the first medical cannabis directory in Australia, it is also the most comprehensive. If you would like […]
Read More
According to their site, The Australian New Zealand Clinical Trials Registry (ANZCTR) is an online register of clinical trials being undertaken in Australia, New Zealand and elsewhere. The ANZCTR includes trials from the full spectrum of therapeutic areas of pharmaceuticals, surgical procedures, preventive measures, lifestyle, devices, treatment and rehabilitation strategies and complementary therapies. At […]
Read More
Global pharma company Jazz Pharmaceuticals has reached an agreement to buy United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid businesses in the world, for $7.2 billion in cash and stock, the drugmakers announced Wednesday. The proposed transaction would be the largest move to date by a pharma company into cannabis, demonstrating that pharmaceutical […]
Read More
According to the Office of Drug Control, Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021 has been has been introduced to Parliament to streamline efficiency around license and permit applications. The Bill will amend the Narcotic Drugs Act 1967 to support the implementation of a number of the recommendations of the Final Report of the Review of […]
Read More
TGA allows OTC sales of Cannabidiol The medical cannabis industry took a big step forward in Australia today with the announcement from the regulator. The Therapeutic Goods Administration or TGA has announced it will down-schedule cannabidiol (CBD) in low dose preparations from Schedule 4 (defined as prescription medications) to Schedule 3 available in pharmacies. According […]
Read More
Innovator in the Medical Cannabis Space in Australia Comes of Age Medical Cannabis Doctors Australia is proud to have been assisting patients to connect with medicinal cannabis doctors for free for more than 4 years. Indeed we were the very first site in Australia to offer this service, and we are delighted to have been […]
Read More
04/12/2020 A historic vote at the United Nations (UN) has recognised the medicinal value of cannabis and removed it from a list of dangerous drugs which are placed under the strictest controls. The drug was previously listed on Schedule IV of the UN Commision on Narcotic Drugs’ list, which features other dangerous and tightly controlled […]
Read More